CPHI China Pharma Holdings Inc.: Operating Profitability

Public company logo of chinapharmaholdings.com (CPHI)

China Pharma Holdings (CPHI) is in its maturity stage, optimizing costs for 2026. Growth is driven by generics and demand across regional clinics in the PRC, although API procurement is outsourced, creating a dependency on suppliers. This chart on GURU.Markets reflects a shift in the operating margin level, where the parameter value equals -119.00, allowing for a correlation between actual profit and market demand.

CPHI: China Pharma Holdings Operating Margin 07/04/2022 - 11/20/2026

China Pharma Holdings Inc. (CPHI) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
- money and cash flow information:
Fundamental company valuation:chinapharmaholdings.com, CPHI
Core merchandise of China Pharma Holdings, Inc.

To objectively evaluate China Pharma Holdings (CPHI), analyzing the efficiency of pharmaceutical production and distribution is critical. The operating margin, as reflected by the operating margin changes on GURU.Markets, is calculated as the ratio of operating profit to revenue, showing the portion of net income derived from every yuan earned. The stability of this ratio confirms management's ability to maintain the profitability of the drug portfolio amid strict government price regulations.